NAGE logo

NAGE Niagen Bioscience Inc

NASDAQ Capital Market · Biotechnology · Healthcare

$1.84
-0.03 (-1.60%)

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulate…

Market Cap: $145.72Mwww.niagenbioscience.com

Price

No data yet.

Social Signal Score

49
5d
—
30d
48
6 mentions
—
60d
49
10 mentions
—
90d
48
13 mentions
—
news: 13

Analyst Ratings

6 analysts
Buyconsensus
Strong Buy 0Buy 6Hold 0Sell 0Strong Sell 0
Avg price target$10+443.5%
Low $10Median $10High $10
Current Consensus

Revenue

$27.19M+381.95%
$3.37M$13.57M$23.78M$33.99M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.18
$0.17–$0.19
3 analysts
FY2026
$0.06-69% YoY
$0.03–$0.09
3 analysts
FY2027
$0.04-29% YoY
$-0.11–$0.15
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Robert N. Fried
Sector
Healthcare
Industry
Biotechnology
Employees
117
Beta
2.09
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
3.73
www.niagenbioscience.com